- In January 2024, Siemens Healthineers received FDA clearance for the MAGNETOM Cima.X, a 3 Tesla MRI scanner featuring the industry's strongest gradient system. This advancement enhances the visibility of smaller structures and accelerates image acquisition, facilitating improved diagnostics in oncology, cardiology, and neurology
- In 2024, GE HealthCare announced the FDA clearance of the SIGNA Champion, a 1.5 Tesla MRI system designed to democratize advanced imaging. It integrates AI technologies such as AIR Recon DL and Sonic DL, offering faster and more precise scans. This system aims to enhance accessibility to high-quality MRI services globally
- In November 2024, Philips unveiled its next-generation BlueSeal MRI system at RSNA 2024. This 1.5T wide-bore scanner operates without helium, reducing operational costs and environmental impact. It features AI-enabled Smart Reading for enhanced diagnostic accuracy and patient throughput
- In June 2024, Philips introduced the UK's first mobile MRI system equipped with BlueSeal technology at the UK Imaging and Oncology Congress. This mobile unit offers flexible and sustainable MRI services, providing high-quality diagnostics in remote and underserved areas
- In 2020, Siemens launched its smallest and most lightweight whole-body MRI, High-V MRI. It has a unique blend of digital technologies and an increased 0.55-tesla field strength, which expands the spectrum of clinical applications for MRI scanners
Frequently Asked Questions
The Integration of artificial intelligence and advanced imaging techniques, is emerging as a pivotal trend driving the global magnetic resonance imaging (MRI) market.
The major factors driving the growth of the magnetic resonance imaging (MRI) market are rising burden of chronic diseases and demand for early diagnosis and as the continuous advancement in MRI technology, growing geriatric population, and expanding applications in early disease detection and personalized medicine
The primary challenges include high equipment and installation costs limiting market accessibility and long scan times, which can impact patient comfort
The oncology segment is expected to dominate the global magnetic resonance imaging (MRI) market holding a major market share in 2025, due to its high demand for detailed imaging in cancer diagnosis and treatment.
Asia-Pacific is the fastest growing region in the global magnetic resonance imaging (MRI) market due to its rapidly developing healthcare infrastructure, increasing awareness of early disease detection, and rising healthcare spending
